Allergan, the maker of the Botox wrinkle treatment, challenged the government's ban on off-label drug marketing to doctors, saying it violates the company's right to freedom of speech.
The company contends in a lawsuit filed Thursday that it should be able to educate doctors about the risks and benefits of using treatments for unapproved uses.
BusinessWeek
Insider's view: a high risk strategy, to say the least!
No comments:
Post a Comment